Astrana health, inc.ASTH.US Overview
ASTH Overall Performance
ASTH AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
ASTH Key Information
ASTH Financial Forecast
Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2025Q1 | ||||
| 2025Q2 | ||||
| 2025Q3 | ||||
| 2025Q4 | ||||
| 2026Q1 |
ASTH Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
ASTH Profile
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Price of ASTH
ASTH FAQ
When is ASTH's latest earnings report released?
The most recent financial report for Astrana health, inc. (ASTH) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ASTH's short-term business performance and financial health. For the latest updates on ASTH's earnings releases, visit this page regularly.
Where does ASTH fall in the P/E River chart?
According to historical valuation range analysis, Astrana health, inc. (ASTH)'s current price-to-earnings (P/E) ratio is 132.38, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of ASTH?
According to the latest financial report, Astrana health, inc. (ASTH) reported an Operating Profit of 19.21M with an Operating Margin of 2.01% this period, representing a decline of 32.42% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is ASTH's revenue growth?
In the latest financial report, Astrana health, inc. (ASTH) announced revenue of 956.05M, with a Year-Over-Year growth rate of 99.71%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does ASTH have?
As of the end of the reporting period, Astrana health, inc. (ASTH) had total debt of 1.09B, with a debt ratio of 0.49. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does ASTH have?
At the end of the period, Astrana health, inc. (ASTH) held Total Cash and Cash Equivalents of 462.23M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does ASTH go with three margins increasing?
In the latest report, Astrana health, inc. (ASTH) did not achieve the “three margins increasing” benchmark, with a gross margin of 10.2%%, operating margin of 2.01%%, and net margin of 0%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ASTH's profit trajectory and future growth potential.
Is ASTH's EPS continuing to grow?
According to the past four quarterly reports, Astrana health, inc. (ASTH)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.01. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of ASTH?
Astrana health, inc. (ASTH)'s Free Cash Flow (FCF) for the period is 7.4M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 76.63% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of ASTH?
The latest valuation data shows Astrana health, inc. (ASTH) has a Price-To-Earnings (PE) ratio of 132.38 and a Price/Earnings-To-Growth (PEG) ratio of -3.42. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.